Immunogenicity of pneumococcal vaccine in liver transplant recipients using a conjugate-polysaccharide priming-booster strategy

Trial Profile

Immunogenicity of pneumococcal vaccine in liver transplant recipients using a conjugate-polysaccharide priming-booster strategy

Completed
Phase of Trial: Phase IV

Latest Information Update: 17 Jan 2017

At a glance

  • Drugs Pneumococcal 7-valent CRM197 vaccine conjugate (Primary) ; Pneumococcal vaccine
  • Indications Pneumococcal infections
  • Focus Pharmacodynamics
  • Most Recent Events

    • 24 Feb 2009 Status changed from active, no longer recruiting to completed, as reported by ISRCTN: Current Controlled Trials.
    • 24 Feb 2009 Actual completion date reported as 28 Feb 2008 by ISRCTN: Current Controled Trials.
    • 06 Jun 2007 Status change
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top